1 / 9

Travel Vaccines Market to 2019 - Research report

The report provides insights into the vaccines in the Travel Vaccines market including market forecasts up to 2019, as well as insights into the Travel Vaccines RandD pipeline. 

sarahjohnsonn
Télécharger la présentation

Travel Vaccines Market to 2019 - Research report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Report: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Report Insights • The travel vaccines market in the top seven markets was valued at USD 1,343 million in 2012, increasing at a CAGR of 11% since 2007 • It is projected to grow at a CAGR of 7.5% during 2012 to 2019 to reach USD 2,224 million • The growth in the travel vaccines market is driven by increased uptake of hepatitis A vaccines • Hepatitis A vaccines is expected to reach USD 423 million in 2019 from USD 264 million in 2012

  2. Report: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Report Coverage • Annualized market data for the travel vaccines market from 2007 to 2012, forecast forward to 2019 • Analysis of the travel vaccines market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan • Market characterization of the travel vaccines market including market size, cost of vaccination • Key drivers and barriers that have a significant impact on the market • Coverage of pipeline molecules in various phases of vaccine development

  3. Report: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Report Coverage (Continued) • Competitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline, Sanofi, Pfizer, Merck and Novartis • Key M&A activities and licensing agreements that have taken place between 2009 and up to January 2013 in the global travel vaccines market

  4. Report: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Report Benefits • Align product portfolio to the markets with high growth potential • Develop market-entry and market expansion strategies by identifying the potential region and travel vaccines market segments poised for strong growth • Create a more tailored country strategy through the understanding of key drivers and barriers of the global Travel Vaccines market • Develop key strategic initiatives by understanding the key focus areas and top selling products of leading companies • Accelerate and strengthen market position by identifying key companies for mergers, acquisitions and strategic partnerships

  5. Report: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Table of Contents • Introduction  • Overview • Market Characterization and Forecast • Hepatitis A Vaccines • Hepatitis B Vaccines • Japanese Encephalitis Vaccines • Meningococcal Vaccines • Rabies Vaccines • Typhoid Vaccines • Yellow Fever Vaccines

  6. Report: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Table of Contents (Continued) • Competitive Landscape • Strategic Consolidations • Vaccines in Asia-Pacific  • Appendix 

  7. Report: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Report Details • Publish date:14th May, 2013 • Number of slides: 116 • Geographic coverage: Global • Available format: PDF, CD, Hardcopy • Price for Single User License: USD 3,500 • Price for Site License: USD 7,000 • Price for Global User License: USD 10,500 • Delivery Time: Within 1 business day • Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal

  8. Interested in this report? To view more details regarding this premium market research report, Please click here For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports

More Related